BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9755237)

  • 1. Efficacy of anti-intercellular adhesion molecule-1 immunotherapy on immune responses to allogeneic hepatocytes in mice.
    Bumgardner GL; Li J; Heininger M; Orosz CG
    Hepatology; 1998 Oct; 28(4):1005-12. PubMed ID: 9755237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor necrosis factor alpha and intercellular adhesion molecule-1 expression on immunogenicity of murine liver cells in mice.
    Bumgardner GL; Li J; Apte S; Heininger M; Frankel WL
    Hepatology; 1998 Aug; 28(2):466-74. PubMed ID: 9696013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
    Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities.
    Stepkowski SM; Tu Y; Condon TP; Bennett CF
    J Immunol; 1994 Dec; 153(11):5336-46. PubMed ID: 7963586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
    He Y; Mellon J; Apte R; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
    Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M
    J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Involvement of ICAM-1/LFA-1 adhesion molecule set in rat orthotopic liver transplantation].
    Omura T
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1220-31. PubMed ID: 7868060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2.
    Gorczynski RM; Fu XM; Issekutz T; Cohen Z
    Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha.
    McHale JF; Harari OA; Marshall D; Haskard DO
    J Immunol; 1999 Feb; 162(3):1648-55. PubMed ID: 9973425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody against lymphocyte function-associated antigen 1 inhibits the formation of primary biliary cirrhosis-like lesions induced by murine graft-versus-host reaction.
    Kimura T; Suzuki K; Inada S; Hayashi A; Isobe M; Matsuzaki Y; Tanaka N; Osuga T; Fujiwara M
    Hepatology; 1996 Oct; 24(4):888-94. PubMed ID: 8855193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
    Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.
    Cosimi AB; Conti D; Delmonico FL; Preffer FI; Wee SL; Rothlein R; Faanes R; Colvin RB
    J Immunol; 1990 Jun; 144(12):4604-12. PubMed ID: 1972162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms.
    Hoefer IE; van Royen N; Rectenwald JE; Deindl E; Hua J; Jost M; Grundmann S; Voskuil M; Ozaki CK; Piek JJ; Buschmann IR
    Circ Res; 2004 May; 94(9):1179-85. PubMed ID: 15059933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 during nonsuppurative destructive cholangitis in a mouse graft-versus-host disease model.
    Howell CD; Li J; Chen W
    Hepatology; 1999 Mar; 29(3):766-76. PubMed ID: 10051478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte-sponge matrix allografts.
    Bumgardner GL; Chen S; Almond PS; Bach FH; Ascher NL; Matas AJ
    Transplantation; 1992 Apr; 53(4):857-62. PubMed ID: 1566351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.